sulfonyldimethaneFinding
Sulfonyldimethane decreases WOMAC pain subscale
lowersVery limited evidenceFinding
01 · The sentence it was drawn from
“Compared to placebo, MSM produced significant decreases in WOMAC pain and physical function impairment (P<0.05).”
sulfonyldimethane
WOMAC pain subscale
lowers
- Who
- n = 50 · Fifty men and women, 40-76 years of age with knee osteoarthritis pain; WOMAC visual analogue scale format
- Dose studied
- MSM 3 g twice a day (6 g/day total) for 12 weeks
Very limited evidencePMID 16309928 · 2006
02 · The study
- Study
- RCT
- Participants
- 50
- Duration
- 3 months
Evidence, by strength
- strong
- moderate
- limited
- very limitedthis finding
- insufficient
03 · The paper
Osteoarthritis and cartilage04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M71G4CXWEGPMH7FRW7YXR8XW